Pfizer lifts 2024 profit view on cost cuts, higher COVID vaccine demand
(Reuters) -Pfizer lifted its annual profit forecast on Wednesday, banking on cost cuts and better-than-expected demand for it...
1h ago
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
COPENHAGEN (Reuters) - Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing...
2h ago
Arizona Senate expected to vote on 1864 abortion ban repeal
By Brad Brooks (Reuters) - The Arizona Senate is expected to vote on Wednesday on a measure to repeal the state's 1864 ban on...
2h ago
Optomed Oyj, AEYE Health say portable device to detect eye issues gets FDA nod
(Reuters) - A portable device that detects eye conditions that can cause sight loss in people with conditions such as diabete...
2h ago
UK's Smith+Nephew retains annual forecasts despite Q1 revenue miss
(Reuters) - British medical equipment maker Smith+Nephew retained its annual revenue and profit forecasts on Wednesday, despi...
4h ago
Haleon's first-quarter revenue misses expectations
(Reuters) - Consumer healthcare company Haleon's first-quarter revenue missed market estimates on Wednesday, due to retailer ...
5h ago
Novo Nordisk owner to invest $200 million in quantum computing startups
By Martin Coulter LONDON (Reuters) - Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, sai...
5h ago
GSK raises full-year profit forecast, says first-half will see stronger sales
(Reuters) -GSK raised its full-year profit forecast on Wednesday and said its sales would be higher in the first six months o...
6h ago
Stryker lifts 2024 profit forecast on strong demand for medical devices, implants
(Adds media packaging code) (Reuters) - Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient dema...
11h ago
Neurocrine Biosciences' Huntington's disease drug gets FDA approval
By Sruthi Narasimha Chari (Reuters) -The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neur...
12h ago